Comment: Neuroleptic Malignant Syndrome Associated with Risperidone and Fluvoxamine

Abstract

Get full access to this article

View all access options for this article.

References

Reeves

Mack

Beddingfield

. Neurotoxic syndrome associated with risperidone and fluvoxamine. Ann Pharmacother 2002;36: 440–3.

Gillman

. Serotonin syndrome: History and risk. Fundam Clin Pharmacol 1998;12: 482–91.

Gillman

. The serotonin syndrome and its treatment. J Psychopharmacol 1999;13: 100–9.

Gillman

. Successful treatment of serotonin syndrome with chlorpromazine. Med J Aust 1996;165: 345–6.

Chan

Graudins

Whyte

Dawson

Braitberg

Duggin

. Serotonin syndrome resulting from drug interactions. Med J Aust 1998;169: 523–5.

Nisijima

Yoshino

Yui

Katoh

. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 2001;890: 23–31.

Nisijima

Yoshino

Ishiguro

. Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology (Berl) 2000;150: 9–14.